One of the IPO that has suffer

Like
Comment
Favorite

金錢弟
2022-09-20

One of the IPO that has suffered huge loss.

Neurostimulation device maker Nexalin stock drops 44% following $10M IPO

Nexalin Technology (NASDAQ:NXL) stock was trading 44% lower on Friday following the medical device d

Neurostimulation device maker Nexalin stock drops 44% following $10M IPO

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":9910631227,"tweetId":"9910631227","gmtCreate":1663623115069,"gmtModify":1676537300689,"author":{"id":3577147550207659,"authorId":3577147550207659,"authorIdStr":"3577147550207659","name":"金錢弟","avatar":"https://community-static.tradeup.com/news/f3b7f4f61fb8c80cae1f168a1a712413","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0},"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>One of the IPO that has suffered huge loss.</p></body></html>","htmlText":"<html><head></head><body><p>One of the IPO that has suffered huge loss.</p></body></html>","text":"One of the IPO that has suffered huge loss.","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/9910631227","repostId":2268161482,"repostType":2,"repost":{"id":"2268161482","pubTimestamp":1663348261,"share":"https://www.laohu8.com/m/news/2268161482?lang=&edition=full","pubTime":"2022-09-17 01:11","market":"us","language":"en","title":"Neurostimulation device maker Nexalin stock drops 44% following $10M IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2268161482","media":"seekingalpha","summary":"Nexalin Technology (NASDAQ:NXL) stock was trading 44% lower on Friday following the medical device d","content":"<html><body> <p>Nexalin Technology (<span>NASDAQ:NXL</span>) stock was trading 44% lower on Friday following the medical device developer's $10M initial public offering.</p> <p>Shares of Nexalin opened at $2.70 after pricing at $4.15 per share. The stock recently changed hands at $2.34 at around 12:45<span> p.m. ET.</span></p> <p>Nexalin offered 2.3M units priced at $4.15 per unit, with each unit consisting of one share plus one warrant to buy one share at $4.15.</p> <p>Underwriters were granted a 45-day option to buy up to 347K additional shares and/or warrants at the IPO price. Maxim Group was serving as sole bookrunner.</p> <p>Based in Texas, Nexalin has been developing neurostimulation devices to treat mental health conditions such as anxiety, insomnia and depression. </p> <p>For a more in-depth look at Nexalin, check out SA contributor Avisol Capital Partners’ “Nexalin: Neurostimulation Therapy for Anxiety and Insomnia.”</p> <div> </div></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Neurostimulation device maker Nexalin stock drops 44% following $10M IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNeurostimulation device maker Nexalin stock drops 44% following $10M IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-17 01:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3883502-neurostimulation-device-maker-nexalin-stock-drops-following-10m-ipo><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nexalin Technology (NASDAQ:NXL) stock was trading 44% lower on Friday following the medical device developer's $10M initial public offering. Shares of Nexalin opened at $2.70 after pricing at $4.15 ...</p>\n\n<a href=\"https://seekingalpha.com/news/3883502-neurostimulation-device-maker-nexalin-stock-drops-following-10m-ipo\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NXL":"Nexalin Technology, Inc."},"source_url":"https://seekingalpha.com/news/3883502-neurostimulation-device-maker-nexalin-stock-drops-following-10m-ipo","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2268161482","content_text":"Nexalin Technology (NASDAQ:NXL) stock was trading 44% lower on Friday following the medical device developer's $10M initial public offering. Shares of Nexalin opened at $2.70 after pricing at $4.15 per share. The stock recently changed hands at $2.34 at around 12:45 p.m. ET. Nexalin offered 2.3M units priced at $4.15 per unit, with each unit consisting of one share plus one warrant to buy one share at $4.15. Underwriters were granted a 45-day option to buy up to 347K additional shares and/or warrants at the IPO price. Maxim Group was serving as sole bookrunner. Based in Texas, Nexalin has been developing neurostimulation devices to treat mental health conditions such as anxiety, insomnia and depression.  For a more in-depth look at Nexalin, check out SA contributor Avisol Capital Partners’ “Nexalin: Neurostimulation Therapy for Anxiety and Insomnia.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":91,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":35,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}